DEEP Missions

We have a vision where pharma, academia, patient groups, technology providers and regulators collaborate pre-competitively to build regulatory-ready digital measures that can be shared and reused across drug development - to help improve the lives of patients. DEEP provides the platform, tools and services that make this kind of collaboration possible.

Browse the missions below - some are open for collaborators now, others are still being scoped. If you have one to propose, we would love to hear from you.

  • There are no suggestions because the search field is empty.

DEEP’s FDA Workshop Mission - Building the Future of DHT Regulatory Evidence & Submissions

This fall, DEEP Measures and members of the Global Advocacy Network (GAN) will convene a focused, one-day workshop with subject matter experts from the FDA's CDER, CDRH, and CBER.The FDA Workshop...

The Pfizer-led Physical Activity Harmonization Mission Has Launched!

Originally published March 5, 2026 · Updated July 27, 2026. The Physical Activity Harmonization Mission is officially underway, having kicked off in late June. This Pfizer-led consortium, in...

Measuring What Matters in Respiratory Disease

Originally published May 14, 2026 · Updated Aug 4, 2026. Digital measurement is increasingly used in respiratory drug development, but the field remains fragmented. Across indications, similar...

Unifying Digital Measures in Parkinson's Disease

Building Digital Measures for PD? DEEP can help! Clinical trials in PD have relied on snapshot, clinic-based assessments for too long. We're changing that: bringing pharma, biotech, researchers,...

Defining New Digital Measures in Myasthenia Gravis

Developing precise and comprehensive digital measures for Myasthenia Gravis (MG) that capture meaningful aspects of the disease and address unmet needs in patient care and drug development.

DEEP/NICE Advice pilot mission: The way medicines reach European patients has changed - the time to prepare is now!

Why this matters now ? Authorities increasingly want exactly what digital measures are built to deliver: continuous, patient-relevant outcomes from wearables, sensors and apps. At the same time, the...